Oxford Biomedica plc (LON:OXB)

Oxford Biomedica Statistics

Total Valuation

LON:OXB has a market cap or net worth of GBP 1.06 billion. The enterprise value is 1.11 billion.

Market Cap	1.06B
Enterprise Value	1.11B

Important Dates

The last earnings date was Wednesday, December 24, 2025.

Earnings Date	Dec 24, 2025
Ex-Dividend Date	n/a

Share Statistics

LON:OXB has 120.75 million shares outstanding. The number of shares has increased by 2.96% in one year.

Current Share Class	120.75M
Shares Outstanding	120.75M
Shares Change (YoY)	+2.96%
Shares Change (QoQ)	+4.23%
Owned by Insiders (%)	0.42%
Owned by Institutions (%)	46.50%
Float	63.13M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	6.99
PB Ratio	32.28
P/TBV Ratio	125.62
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-29.90
EV / Sales	7.33
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-92.12

Financial Position

The company has a current ratio of 1.89, with a Debt / Equity ratio of 3.22.

Current Ratio	1.89
Quick Ratio	1.59
Debt / Equity	3.22
Debt / EBITDA	n/a
Debt / FCF	-8.76
Interest Coverage	-2.28

Financial Efficiency

Return on equity (ROE) is -75.20% and return on invested capital (ROIC) is -32.56%.

Return on Equity (ROE)	-75.20%
Return on Assets (ROA)	-7.44%
Return on Invested Capital (ROIC)	-32.56%
Return on Capital Employed (ROCE)	-18.72%
Revenue Per Employee	168,016
Profits Per Employee	-41,183
Employee Count	850
Asset Turnover	0.66
Inventory Turnover	5.25

Taxes

In the past 12 months, LON:OXB has paid 1.53 million in taxes.

Income Tax	1.53M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +109.16% in the last 52 weeks. The beta is 1.00, so LON:OXB's price volatility has been similar to the market average.

Beta (5Y)	1.00
52-Week Price Change	+109.16%
50-Day Moving Average	665.98
200-Day Moving Average	498.54
Relative Strength Index (RSI)	72.11
Average Volume (20 Days)	356,250

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, LON:OXB had revenue of GBP 151.21 million and -37.07 million in losses. Loss per share was -0.36.

Revenue	151.21M
Gross Profit	66.72M
Operating Income	-27.44M
Pretax Income	-37.56M
Net Income	-37.07M
EBITDA	-12.57M
EBIT	-27.44M
Loss Per Share	-0.36

Balance Sheet

The company has 53.88 million in cash and 105.42 million in debt, with a net cash position of -51.55 million or -0.43 per share.

Cash & Cash Equivalents	53.88M
Total Debt	105.42M
Net Cash	-51.55M
Net Cash Per Share	-0.43
Equity (Book Value)	32.73M
Book Value Per Share	0.31
Working Capital	62.07M

Cash Flow

In the last 12 months, operating cash flow was -7.84 million and capital expenditures -4.19 million, giving a free cash flow of -12.03 million.

Operating Cash Flow	-7.84M
Capital Expenditures	-4.19M
Free Cash Flow	-12.03M
FCF Per Share	-0.10

Margins

Gross margin is 44.12%, with operating and profit margins of -18.15% and -24.51%.

Gross Margin	44.12%
Operating Margin	-18.15%
Pretax Margin	-24.84%
Profit Margin	-24.51%
EBITDA Margin	-8.31%
EBIT Margin	-18.15%
FCF Margin	n/a

Dividends & Yields

LON:OXB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.96%
Shareholder Yield	-2.96%
Earnings Yield	-3.51%
FCF Yield	-1.14%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on May 30, 2018. It was a reverse split with a ratio of 0.02.

Last Split Date	May 30, 2018
Split Type	Reverse
Split Ratio	0.02

Scores

LON:OXB has an Altman Z-Score of -0.87 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.87
Piotroski F-Score	4